1GA
MYGN icon

1st Global Advisors’s Myriad Genetics MYGN Stock Holding History

1st Global Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,899
Closed -$235K – 486
2014
Q4 		$235K Sell
6,899
-1,444
-17% -$51.2K 0.03% 395
2014
Q3 		$322K Buy
8,343
+151
+2% +$5.63K 0.05% 289
2014
Q2 		$319K Sell
8,192
-232
-3% -$8.63K 0.05% 284
2014
Q1 		$288K Sell
8,424
-11,196
-57% -$347K 0.05% 282
2013
Q4 		$412K Buy
19,620
+5,884
+43% +$149K 0.08% 196
2013
Q3 		$323K Sell
13,736
-1,470
-10% -$41.8K 0.07% 240
2013
Q2 		$409K Buy
+15,206
New +$441K 0.09% 156

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1st Global Advisors's MYGN Position: Q1 2015 in Review

1st Global Advisors sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 6,899 shares — an estimated $235K sold.

1st Global Advisors first reported a position in MYGN in Q2 2013 and held it in 7 quarters. The position peaked at $412K in Q4 2013. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

  • 1st Global Advisors reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
  • 1st Global Advisors sold 6,899 Myriad Genetics shares in Q1 2015, an estimated $235K.
  • 1st Global Advisors first reported a position in Myriad Genetics in Q2 2013 and held it in 7 quarters.
  • 1st Global Advisors's Myriad Genetics position peaked at $412K in Q4 2013.
  • 251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on 1st Global Advisors's 13F filing for Q1 2015, filed 1 May 2015.